Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia

Detalles Bibliográficos
Autores principales: Vadlamani, Laxmi Naresh, Banwari, Girish, Dinakaran, Damodharan, Menon, Vikas, Andrade, Chittaranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Letters to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547874/
https://www.ncbi.nlm.nih.gov/pubmed/28827880
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_95_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547874/
https://www.ncbi.nlm.nih.gov/pubmed/28827880
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_95_17

Ejemplares similares